Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

PhRMA Statement on Comments to CMS Regarding Proposed Part D Rule and RFI Exploring Pass-Through Rebates to Seniors at Point of Sale

January 16, 2018

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments to the Centers for Medicare & Medicaid Services regarding the proposed rule, “Contract Year 2019 Policy and Technical Changes to the Medicare Advantage Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program.”

Read More

ICYMI: Why 2017 medicine approvals matter

January 12, 2018

The FDA just approved the highest amount of innovative new medicines in over 20 years.

Read More

Clarity around anti-kickback statute needed to promote innovative payment arrangements

January 10, 2018

The broad terms of the anti-kickback statute are limiting the number and scope of innovative results-based contracts; a safe harbor is needed.

Read More

PhRMA Statement on 340B PAUSE Act

December 21, 2017

The legislation introduced today by Representatives Larry Bucshon and Scott Peters is yet another important action taken this year to begin to address the problems in the 340B program.

Read More

Medicare Monday: Helping beneficiaries access vaccines

December 18, 2017

Strengthening seniors’ access to vaccines through Part D is critically important.

Read More

NHE Data: Medicine spending grew just 1.3 percent in 2016

December 12, 2017

According to new data from the National Health Expenditures (NHE), retail medicine spending grew just 1.3 percent in 2016, down from 9 percent in 2015.

Read More

PhRMA Announces Major Commitment to Address the Opioid Crisis in America

December 12, 2017

PhRMA announced a new multi-year, multimillion dollar initiative to address the opioid crisis, which will include a partnership with the Addiction Policy Forum to fund state and local programs, as well as support for new public policies that help families and individuals impacted by the crisis.

Read More

ICYMI Report highlights increasing prevalence for Alzheimer's disease

December 11, 2017

The number of Americans affected by Alzheimer's disease (AD) continues to rise according to a new report by the Alzheimer’s Association.

Read More

PhRMA Challenges Unconstitutional Provisions of California’s SB 17 in Federal Court

December 8, 2017

Today, PhRMA initiated litigation in the United States District Court for the Eastern District of California challenging SB 17, an unprecedented and unconstitutional California law.

Read More

New surveys find payers and providers want more data from biopharmaceutical companies

December 6, 2017

Survey of payers and providers suggests need and value of increased biopharmaceutical company communications with health care stakeholders.

Read More
prev 1 2 3 4 5 6 next